The future of rhabdomyosarcoma trials

Lancet Child Adolesc Health. 2022 Aug;6(8):510-511. doi: 10.1016/S2352-4642(22)00132-8. Epub 2022 Jun 9.

Author

Monika Sparber-Sauer¹

Affiliation

¹ Hospital of the State Capital Stuttgart gKAöR, Center for Pediatric, Adolescent and Women's Medicine, Central location (Olgahospital), D-70174 Stuttgart, Germany. Electronic address: m.sparber-sauer@klinikum-stuttgart.de.

PMID: 35690070
DOI: 10.1016/S2352-4642(22)00132-8

No abstract available

Publication types

Comment

MeSH terms

Disease-Free Survival
Humans
Rhabdomyosarcoma* / therapy